BIT

5.00%

1.9¢ biotron limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-79

First 79 Last

Share
Profile

Follow
luxury

3,599 Posts.

331

04/08/24

23:33

Post #: 75065917
Share

Originally posted by vrs37: ↑

Wow. I was looking back on my last posts about BIT, it's been > 3 years. I questioned then what was the point of this company, said then how it looked little more than an academic's hobby and asked who was propping up this outfit. I said in a post from March 2021 I'd return in March 2024 to see what they're doing, well here I am, sorry bit late.

>>>Hmm, not much has changed, SP is at 40% of what it was back then but good to see one staff member being kept employed.
>>> They are still "synthesising and designing" stuff which is pretty much what they said 3 years ago I recall. A 10th century druid could come up with something quicker and more effective.
>>>They do seem to have advanced a couple of tiny HIV phase 2 trial, basically at snails pace, is that about the extent of it since 2021? Now off looking into zika and dengue? Why???? How about Monkey pox. Maybe the greyscale from Game of Thrones might be a better disease target.

>>>Really nothing has changed, has it? The SH letter from last month read like little more than a "please stick with us, we're really really trying, it's all quite hard you know, oh yeah I'd still like to be CEO". Shocking indictment of the Aus biotech sector. No CEO should last 20+ years in position. It's looks suspiciously like a sinecure. If their science and technology really are genuine & credible, why not overhaul board and CEO, bring in fresh minds who really have the competence and ambition to push this forward? The clinical development lacks urgency, there's no strategy from what I see apart from going after any virus that takes their fancy, and no evidence of commercial competence. Many of their peers in the sector at least regularly post to social media like LinkedIn to show what they're doing, elevating their profile, getting out there. This outfit has no LI page, no postings, no profile. Seriously what do they do day to day?

All IMO.

Expand

Clearly you are ill informed as to the colossal strides Biotron has made in the 3 years of your absence, they have left the field of viruses, which, let’s face it, is just kids stuff. No!, they are going for the holy grail - Cancer, Michelle has set her mind to it to get rid of it forever.
Not long now.

BIT Price at posting: 3.1¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

IMA

Issues emerging as Australian companies tackle critical minerals challenge

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 81 more messages in this thread...

First 79 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 1.9¢		Change -0.001(5.00%)		Mkt cap ! $17.14M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.9¢	$820	43.17K

Buyers (Bids)

No.	Vol.	Price($)
12	1845030	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	41100	1

View Market Depth

No.	Vol.	Price($)
12	1845030	0.019
9	1690748	0.018
9	2358408	0.017
12	1659350	0.016
6	765000	0.015

Price($)	Vol.	No.
0.020	41100	1
0.021	647442	4
0.022	1107935	5
0.023	1100772	2
0.024	112849	1

Last trade - 14.27pm 11/10/2024 (20 minute delay)

BIT (ASX) Chart

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-79

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Issues emerging as Australian companies tackle critical minerals challenge

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Defence MOU for propulsion systems pushes Aurora Lab shares higher

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Cauldron Energy reports "excellent" uranium assays in latest drill run

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-79

Top Stories

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Issues emerging as Australian companies tackle critical minerals challenge

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Defence MOU for propulsion systems pushes Aurora Lab shares higher

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Cauldron Energy reports "excellent" uranium assays in latest drill run

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News